This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

ZIKAVAC (Inactivated Virus)

Bharat Biotech

Drug Names(s): Zika Vaccine, ZIKAVAC

Description: Bharat Biotech is developing ZIKAVAC, a Zika vaccine, using inactivated virus.

ZIKAVAC (Inactivated Virus) News

Scrip Import Tax Waivers As China Slowly Reopens Amid Virus Battle

Scrip Best Practices In Seasonal Vaccine Efficacy Studies: Tips For Successful Planning And Execution

Pink Sheet Chikungunya Vaccine Development May Rely On Immunologic Biomarkers Instead Of Traditional Trials

Scrip Oncorus Raises $79.5m To Take Its First Oncolytic Virus Into The Clinic

Additional information available to subscribers only:

Targets
Routes
Catalysts
Designations
Events

Request a Free Demo Subscriber Login Search for another drug